Menu

NEW YORK (GenomeWeb News) – Laboratory Corporation of American Holdings today announced a definitive agreement to purchase Genzyme Genetics for $925 million in an all-cash deal.

LabCorp will purchase the Genetics segment in its entirety, including all testing services, technology, intellectual property rights, and its nine testing laboratories. LabCorp is "committed" to offer employment to all of Genzyme Genetics' approximately 1,900 employees, including senior management, Genzyme said.

The Human Gene Mutation Database (HGMD) is a manually curated, comprehensive collection of disease-causing, germline mutations. Since 1996, a team of experts has manually catalogued over a quarter of a million mutations for the database.

This webinar will review a recent study that applied whole-genome sequencing and optical genome mapping to identify a large number of previously undetected somatic structural variants in leukemia samples.